Repositioning the role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on the TRAIL to the development of diabetes mellitus: An update of …
C Koliaki, N Katsilambros - International journal of molecular sciences, 2022 - mdpi.com
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a member of the
TNF protein superfamily, represents a multifaceted cytokine with unique biological features …
TNF protein superfamily, represents a multifaceted cytokine with unique biological features …
On the TRAIL of obesity and diabetes
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) has been extensively
studied for its preferential ability to induce apoptosis of cancer cells. Beyond the cytotoxic …
studied for its preferential ability to induce apoptosis of cancer cells. Beyond the cytotoxic …
TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice
Aims/hypothesis TNF-related apoptosis-inducing ligand (TRAIL) is implicated in the
regulation of diabetes and is reduced in patients with cardiovascular disease. Although …
regulation of diabetes and is reduced in patients with cardiovascular disease. Although …
[HTML][HTML] Immunomodulatory Functions of TNF-Related Apoptosis-Inducing Ligand in Type 1 Diabetes
M Fogarasi, S Dima - Cells, 2024 - mdpi.com
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the
TNF protein superfamily and was initially identified as a protein capable of inducing …
TNF protein superfamily and was initially identified as a protein capable of inducing …
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?
S Bernardi, R Voltan, E Rimondi, E Melloni… - Clinical …, 2019 - portlandpress.com
Ligands and receptors of the tumor necrosis factor (TNF) superfamily regulate immune
responses and homeostatic functions with potential diagnostic and therapeutic implications …
responses and homeostatic functions with potential diagnostic and therapeutic implications …
[HTML][HTML] TNF-related apoptosis-inducing ligand (TRAIL) as the potential therapeutic target in hematological malignancies
Despite numerous attempts to find the treatment strategies that can selectively target the
cancer cells, cancer still remains a major public health problem. Conventional cancer …
cancer cells, cancer still remains a major public health problem. Conventional cancer …
Therapeutic potential of VIP vs PACAP in diabetes
AD Sanlioglu, B Karacay, MK Balci… - Journal of …, 2012 - jme.bioscientifica.com
Type 2 diabetes (T2D) is characterized by chronic insulin resistance and a progressive
decline in beta-cell function. Although rigorous glucose control can reduce morbidity and …
decline in beta-cell function. Although rigorous glucose control can reduce morbidity and …
Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancer
Apo 2 ligand/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (Apo2L/TRAIL),
is a member of the TNF family of cytokines, which can induce apoptotic cell death in cells …
is a member of the TNF family of cytokines, which can induce apoptotic cell death in cells …
Treatment with recombinant tumor necrosis factor–related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes
OBJECTIVE To evaluate the potential therapeutic effect of recombinant human tumor
necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) treatment in a model of type …
necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) treatment in a model of type …
Gene and cell therapy of human genetic diseases: Recent advances and future directions
Disruptions in normal development and the emergence of health conditions often result from
the malfunction of vital genes in the human body. Decades of scientific research have …
the malfunction of vital genes in the human body. Decades of scientific research have …